摘要
目的：探析蒙脱石散与儿泻停联合用药下小儿急性腹泻病的临床疗效与安全性。方法：从2014年1月～2015年2月入住我院的急性腹泻患儿中随机选取92例作为研究对象。并按随机分组法分为观察组和对照组,各46例。观察组实施蒙脱石散与儿泻停联合治疗,对照组给予单纯蒙脱石散治疗,对比两组患儿的临床疗效、症状复常时间、住院时间及不良反应情况。结果：观察组的总有效率为97.83%,显著高于对照组的84.78%,且腹泻、呕吐、发热复常时间及住院时间明显少于对照组（P〈0.05）,上述差异均有统计学意义。观察组的不良反应发生率为2.17%,低于对照组的8.70%（P〉0.05）,差异无统计学意义。结论：蒙脱石散与儿泻停联合不仅能有效治疗小儿急性腹泻,缩短临床症状复常时间,且安全性高,值得临床推荐。
Objective： To study the clinical efficacy and safety of acute diarrhea in children of Montmorillonite powder with erxieting combined medication. Methods：From January 2014～February 2015 in our hospital with acute diarrhea were randomly selected 92 cases as the research object, which were randomly divided into observation group and control group, 46 cases in each. The observation group received Montmorillonite powder with erxieting combined treatment, control group was treated with Montmorillonite powder treatment. The symptoms, clinical curative effect were compared between the two groups in the recovery time, hospitalization time and adverse reaction. Results： The total effective rate of observation group was 97.83%, significantly higher than that of the control group was 84.78%, and diarrhea, vomiting, fever recovery time and hospitalization time was significantly less than that of the control group （P〈0.05）. These differences were statistically significant. Incidence of adverse reactions in observation group was 2.17%, lower than that of the control group was 8.70%（P〉0.05）, but the difference was not statistically significant. Conclusion： Montmorillonite powder with erxieting joint not only can be effective in the treatment of acute diarrhea in children the clinical symptoms, shorten the recovery time, and high safety, is worthy of recommendation.
出处
《北方药学》
2015年第7期134-135,共2页
Journal of North Pharmacy
关键词
蒙脱石散
儿泻停
小儿急性腹泻
疗效
安全性
Montmorillonite powder Erxieting Children with acute diarrhea Efficacy Safety
